Utah Medical Products, Inc.
UTMD
$56.25
$0.7651.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.95M | 9.71M | 9.16M | 10.01M | 10.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.95M | 9.71M | 9.16M | 10.01M | 10.40M |
| Cost of Revenue | 4.36M | 4.17M | 3.84M | 4.20M | 4.15M |
| Gross Profit | 5.60M | 5.54M | 5.32M | 5.80M | 6.25M |
| SG&A Expenses | 1.98M | 1.92M | 1.94M | 1.87M | 1.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.48M | 6.24M | 5.89M | 6.25M | 6.33M |
| Operating Income | 3.48M | 3.47M | 3.27M | 3.76M | 4.07M |
| Income Before Tax | 3.84M | 3.86M | 3.61M | 4.18M | 4.21M |
| Income Tax Expenses | 788.00K | 817.00K | 712.00K | 616.00K | 758.00K |
| Earnings from Continuing Operations | 3.05M | 3.04M | 2.90M | 3.56M | 3.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.05M | 3.04M | 2.90M | 3.56M | 3.45M |
| EBIT | 3.48M | 3.47M | 3.27M | 3.76M | 4.07M |
| EBITDA | 4.22M | 4.18M | 3.98M | 4.48M | 4.75M |
| EPS Basic | 0.94 | 0.92 | 0.86 | 1.02 | 0.98 |
| Normalized Basic EPS | 0.79 | 0.79 | 0.73 | 0.83 | 0.86 |
| EPS Diluted | 0.94 | 0.92 | 0.86 | 1.02 | 0.98 |
| Normalized Diluted EPS | 0.79 | 0.79 | 0.73 | 0.83 | 0.86 |
| Average Basic Shares Outstanding | 3.25M | 3.31M | 3.39M | 3.48M | 3.53M |
| Average Diluted Shares Outstanding | 3.25M | 3.31M | 3.39M | 3.48M | 3.53M |
| Dividend Per Share | 0.31 | 0.31 | 0.31 | 0.30 | 0.30 |
| Payout Ratio | 32.84% | 33.44% | 35.77% | 29.53% | 31.31% |